Schubert & CO Moderna, Inc. Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$135.66 - $197.02 $3,527 - $5,122	-26 Reduced 36.11%	46 $7,000
Q4 2022 Jan 31, 2023	BUY	$118.38 - $210.04 $4,498 - $7,981	38 Added 111.76%	72 $12,000
Q3 2022 Oct 21, 2022	SELL	$118.07 - $194.18 $826 - $1,359	-7 Reduced 17.07%	34 $4,000
Q2 2022 Aug 01, 2022	BUY	$117.13 - $176.59 $3,279 - $4,944	28 Added 215.38%	41 $6,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $885 - $1,645	7 Added 116.67%	13 $2,000
Q4 2021 Jan 28, 2022	BUY	$225.82 - $368.51 $1,354 - $2,211	6 New	6 $2,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.